Literature DB >> 35131923

Induction Therapy in Immunologically Well-Matched Recipients: Less May Be More.

Vishnu S Potluri1, Roy D Bloom2.   

Abstract

Entities:  

Keywords:  induction therapy

Mesh：

Year:  2022        PMID： 35131923      PMCID： PMC8823936          DOI： 10.2215/CJN.16591221

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


× No keyword cloud information.
  11 in total

1.  Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients.

Authors:  D C Brennan; K Flavin; J A Lowell; T K Howard; S Shenoy; S Burgess; S Dolan; J M Kano; M Mahon; M A Schnitzler; R Woodward; W Irish; V Ramachamdra; G G Singer
Journal:  Transplant Proc       Date:  1999-05       Impact factor: 1.066

2.  KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

Authors:  Bertram L Kasiske; Martin G Zeier; Jeremy R Chapman; Jonathan C Craig; Henrik Ekberg; Catherine A Garvey; Michael D Green; Vivekanand Jha; Michelle A Josephson; Bryce A Kiberd; Henri A Kreis; Ruth A McDonald; John M Newmann; Gregorio T Obrador; Flavio G Vincenti; Michael Cheung; Amy Earley; Gowri Raman; Samuel Abariga; Martin Wagner; Ethan M Balk
Journal:  Kidney Int       Date:  2009-10-21       Impact factor: 10.612

3.  Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.

Authors:  Oliver Thomusch; Michael Wiesener; Mirian Opgenoorth; Andreas Pascher; Rainer Peter Woitas; Oliver Witzke; Bernd Jaenigen; Markus Rentsch; Heiner Wolters; Thomas Rath; Tülay Cingöz; Urs Benck; Bernhard Banas; Christian Hugo
Journal:  Lancet       Date:  2016-11-19       Impact factor: 79.321

4.  Alemtuzumab induction in renal transplantation.

Authors:  Michael J Hanaway; E Steve Woodle; Shamkant Mulgaonkar; V Ram Peddi; Dixon B Kaufman; M Roy First; Richard Croy; John Holman
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

5.  Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

Authors:  Daniel C Brennan; John A Daller; Kathleen D Lake; Diane Cibrik; Domingo Del Castillo
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

6.  OPTN/SRTR 2019 Annual Data Report: Kidney.

Authors:  A Hart; K L Lentine; J M Smith; J M Miller; M A Skeans; M Prentice; A Robinson; J Foutz; S E Booker; A K Israni; R Hirose; J J Snyder
Journal:  Am J Transplant       Date:  2021-02       Impact factor: 8.086

7.  Use and Outcomes of Induction Therapy in Well-Matched Kidney Transplant Recipients.

Authors:  Rhys D R Evans; James H Lan; Matthew Kadatz; Sandeep Brar; Doris T Chang; Lachlan McMichael; Jagbir Gill; John S Gill
Journal:  Clin J Am Soc Nephrol       Date:  2022-02       Impact factor: 10.614

8.  A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.

Authors:  William C Goggins; Manuel A Pascual; John A Powelson; Colm Magee; Nina Tolkoff-Rubin; Mary Lin Farrell; Dicken S C Ko; Winfred W Williams; Anil Chandraker; Francis L Delmonico; Hugh Auchincloss; A Benedict Cosimi
Journal:  Transplantation       Date:  2003-09-15       Impact factor: 4.939

9.  Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients.

Authors:  Christian Noël; Daniel Abramowicz; Dominique Durand; Georges Mourad; Philippe Lang; Michèle Kessler; Bernard Charpentier; Guy Touchard; François Berthoux; Pierre Merville; Nacera Ouali; Jean-Paul Squifflet; François Bayle; Karl Martin Wissing; Marc Hazzan
Journal:  J Am Soc Nephrol       Date:  2009-05-21       Impact factor: 10.121

10.  Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice.

Authors:  Vikas R Dharnidharka; Abhijit S Naik; David A Axelrod; Mark A Schnitzler; Zidong Zhang; Sunjae Bae; Dorry L Segev; Daniel C Brennan; Tarek Alhamad; Rosemary Ouseph; Ngan N Lam; Mustafa Nazzal; Henry Randall; Bertram L Kasiske; Mara McAdams-Demarco; Krista L Lentine
Journal:  Transpl Int       Date:  2017-11-02       Impact factor: 3.782
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.